Tag: Trulicity

In late 2024, pharmaceutical company AstraZeneca discontinued Bydureon and Bydureon BCise, leaving many patients who relied on the once-weekly injection to seek new options. While there is no direct generic for the drug, known by its active ingredient extended-release exenatide, several other medications within the same class offer similar therapeutic benefits. Understanding **what is equivalent to Bydureon** is now essential for making a smooth and effective transition with a healthcare provider.

In recent years, prescription rates for GLP-1 receptor agonists have surged, with one recent report indicating over 2% of US adults used a GLP-1 for weight loss in 2024 alone. Ozempic is a well-known member of this class, but many people ask: what other drugs are in the same class as Ozempic? This class of medications includes both similar GLP-1 receptor agonists and newer, related dual-action therapies.

According to medical reviews and drug interaction databases, there are no reported interactions between atorvastatin and Trulicity, making their co-administration generally safe. For many patients with co-occurring high cholesterol and type 2 diabetes, a doctor may prescribe both medications to effectively manage these related conditions.

While Mounjaro and Trulicity are both once-weekly injectable medications for Type 2 diabetes, they are not the same thing. Mounjaro (tirzepatide) acts on two different hormone receptors, while Trulicity (dulaglutide) only acts on one, leading to different effects on blood sugar control, weight management, and approved uses.

According to clinical trials, allergic reactions, some severe, occurred in 0.5% of people taking Trulicity (dulaglutide). Yes, Trulicity can cause hives, which can indicate either a localized injection site reaction or a more serious systemic allergic response. It's crucial for patients to understand the difference and know when to seek immediate medical attention.

According to the CDC, over 38 million Americans have diabetes, and medications like Trulicity are crucial for management. If you're wondering, "What is another name for Trulicity injection?", the answer is its generic, non-branded name, dulaglutide.

Trulicity (dulaglutide) is a brand-name biologic drug, and for that reason, there is currently no generic for Trulicity. The medication will remain a brand-only product until its patent protections expire, with a potential biosimilar arriving as early as 2027.

While both Trulicity and Bydureon are injectable, once-weekly medications for managing Type 2 diabetes, they are not the same drug. These two common treatments belong to the same class of drugs but have distinct active ingredients, usage protocols, and varying cardiovascular benefits.

The manufacturer AstraZeneca discontinued both Bydureon BCise and its predecessor Byetta in late 2024, leaving many patients searching for a suitable replacement for Bydureon. As a glucagon-like peptide-1 (GLP-1) receptor agonist, Bydureon's primary function was to help manage blood sugar in adults with Type 2 diabetes. Fortunately, a variety of alternative medications are available, including newer GLP-1 agonists and other classes of diabetes drugs.

Recent years have seen unprecedented shortages of critical diabetes medications, primarily driven by a 300% surge in prescriptions for GLP-1 agonists between 2018 and 2023 [1.4.4]. This article explores what diabetic medication is there a shortage of and what steps patients can take.